ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

IL13-PE38 Looks Promising In Early Tests Against Gioma

September 27, 2002

NCI Awards $15M For Studies Of Glycobiology.

September 28, 2007

AACR Campaigns For Doubling Funding for Cancer Research In Three Years

April 25, 1997

14 Institutions Awarded $100 Million for AIDS Treatment Evaluation Units

July 4, 1986

In Brief: New York Legislature Votes $240 Mil. Bond Issue For Roswell Park Construction; Kripke Honored

April 25, 1992

AACR To Hold Separate Annual Meeting, Seeks ‘More Meaningful’ Interaction With Clinicians

May 29, 1992